Shares of Advanced Oncotherapy plc (LON:AVO – Get Free Report) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 1.77 ($0.02) and traded as low as GBX 1.75 ($0.02). Advanced Oncotherapy shares last traded at GBX 1.75 ($0.02), with a volume of 200,000 shares trading hands.
Advanced Oncotherapy Price Performance
The company has a market cap of £9.49 million, a PE ratio of -25.00 and a beta of 0.07. The company has a quick ratio of 0.13, a current ratio of 1.26 and a debt-to-equity ratio of 98.71. The firm has a 50 day simple moving average of GBX 1.75 and a 200-day simple moving average of GBX 1.77.
Advanced Oncotherapy Company Profile
Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties.
Read More
- Five stocks we like better than Advanced Oncotherapy
- Airline Stocks – Top Airline Stocks to Buy Now
- Garmin Navigates to New Highs Driven By Wearables Trend
- Short Selling: How to Short a Stock
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- What is the Shanghai Stock Exchange Composite Index?
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Advanced Oncotherapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy and related companies with MarketBeat.com's FREE daily email newsletter.
